Xiaoxue Liu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Liquid Chromatography

Top Venues

Annals of laboratory medicine

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoliang Ding, Shengxiong Zhu, Linsheng Liu, Xiaoxue Liu, Kouzhu Zhu, Liyan Miao
Comparison of Target- and IgG-Enrichment Strategies to Measure Adalimumab Concentrations in Human Plasma Using an Immunocapture-Liquid Chromatography-High-Resolution Mass Spectrometry Platform. Annals of laboratory medicine 44 (5) (2024)
Xiaoliang Ding, Shengxiong Zhu, Linsheng Liu, Xiaoxue Liu, Kouzhu Zhu, Liyan Miao
Comparison of Target- and IgG-Enrichment Strategies to Measure Adalimumab Concentrations in Human Plasma Using an Immunocapture-Liquid Chromatography-High-Resolution Mass Spectrometry Platform. Annals of laboratory medicine (2024)
Xiaoliang Ding, Shengxiong Zhu, Linsheng Liu, Xiaoxue Liu, Kouzhu Zhu, Liyan Miao
Comparison of Target- and IgG-Enrichment Strategies to Measure Adalimumab Concentrations in Human Plasma Using an Immunocapture-Liquid Chromatography-High-Resolution Mass Spectrometry Platform. Annals of laboratory medicine 44 (5) (2024)
Xiaoliang Ding, Shengxiong Zhu, Linsheng Liu, Xiaoxue Liu, Kouzhu Zhu, Liyan Miao
Comparison of Target- and IgG-Enrichment Strategies to Measure Adalimumab Concentrations in Human Plasma Using an Immunocapture-Liquid Chromatography-High-Resolution Mass Spectrometry Platform. Annals of laboratory medicine 44 (5) (2024)
Xiaoxue Liu, Ling Xue, Hua Zhang, Qingqing Xu, Shichao Zhang, Sheng Ma, Xiaoliang Ding, Linsheng Liu, Ji Dong, Lifang Qian, Wen Xia, Kun Jiang, Chenrong Huang, Liyan Miao
Phase I, First-in-Human, Single and Multiple Ascending Dose- and Food-Effect Studies to Assess the Safety, Tolerability and Pharmacokinetics of a Novel Anti-hepatitis B Virus Drug, Bentysrepinine (Y101), in Healthy Chinese Subjects. Clinical drug investigation 40 (6) (2020)